Mortality in pediatric renal transplant: Experience of 15 years;Mortalité en transplantation rénale pédiatrique: 15 Ans d'expérience

Archives de Pediatrie

Volumn 11, Issue 8, 2004, Pages 916-920

  Harzallah, K ^a   Floret, D ^b   Martin, X ^b   Cochat, P ^c  

^a MILITARY HOSPITAL OF TUNIS   (Tunisia)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Child; Kidney transplantation, mortality; Mortalit ; Transplantation r nale

Indexed keywords

METHYLPREDNISOLONE; OKT 3;

ACUTE GRAFT REJECTION; ADOLESCENT; ARTICLE; BACTERIAL INFECTION; BURKITT LYMPHOMA; CADAVER DONOR; CAUSE OF DEATH; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DATA ANALYSIS; DIALYSIS; DISEASE DURATION; FOLLOW UP; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFORMATION PROCESSING; KIDNEY DONOR; KIDNEY GRAFT; MAJOR CLINICAL STUDY; NEUROLOGICAL COMPLICATION; NEWBORN; ORGAN DONOR; REOPERATION; RISK ASSESSMENT; RISK FACTOR; SUDDEN DEATH; SURGICAL MORTALITY; SURVIVAL RATE; TIME OF DEATH;

ACTUARIAL ANALYSIS; ADOLESCENT; AGE DISTRIBUTION; BACTERIAL INFECTIONS; BURKITT LYMPHOMA; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CYTOMEGALOVIRUS INFECTIONS; DEATH, SUDDEN; FRANCE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; INFANT; INFECTION CONTROL; KIDNEY TRANSPLANTATION; MORBIDITY; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TIME FACTORS; TISSUE DONORS;

EID: 3442875584     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2004.03.129     Document Type: Article

References (16)

1. Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y., et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant. N Engl J Med. 341:1999;1725-1730
2. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). section 7 - 1 morbidity, malignancy and mortality.:2001
3. Van Damme-Lombaerts R., Herman J., Coosemans W., Pirenne J. Pediatric renal transplantation: A single Belgian center experience over 20 years. Pediatr Transplant. 5:2001;447-451
4. Salvatierra O., Alfrey E., Tanney D.C., Mak R., Hammer G.B., Krane E.J., et al. Superior outcomes in pediatric renal transplantation. Arch Surg. 132:1997;842-847. discussion 847-9
5. Pintos Morell G., Niaudet P., Jean G., Descamps-Latscha B. Altered oxidative metabolism, motility, and adherence in phagocytic cells from cystinotic children. Pediatr Res. 19:1985;1318-1321
6. Saraiva J.M., Dinis A., Resende C., Faria E., Gomes C., Correia A.J., et al. Schimke immuno-osseous dysplasia: case-report and review of 25 patients. J Med Genet. 36:1999;786-789
7. Rapport du conseil médical et scientifique de l'É tablissement français des Greffes. Le prélèvement et la greffe en France en 1998. Établissement français des Greffes. 2000
8. Warady B.A., Herbert D., Sullivan E.K., Alexander S.R., Tejani A. Renal transplantation, chronic dialysis and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol. 11:1997;49-64
9. Tejani A., Sullivan E.K., Alexander S., Fine R., Harmon W., Lilienfeld D. Post-transplant deaths and factors that influence the mortality rate in North American children. Transplantation. 57:1994;547-553
10. Chavers B.M., Gillingham K.J., Matas A.J. Complications by age in primary pediatric renal transplant recipients. Pediatr Nephrol. 11:1997;399-403
11. Loirat C., Maisin A., Baudouin V. Transplantation rénale chez l'enfant: accès aux organes, résultats et perspectives. Journées parisiennes de Pédiatrie. 2000;197-208 Flammarion Médecine-Sciences, Paris
12. Lowance D., Neumayer H.H., Legendre C.M., Squifflet J.P., Kovarik J., Brennan P.J., et al. Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group. N Engl J Med. 340:1999;1462-1470
13. Brennan D.C., Garlock K.A., Singer G.G., Schnitzler M.A., Lippmann B.J., Buller R.S., et al. Prophylactic oral ganciclovir compared with deferred therapy for control of cytomegalovirus in renal transplant recipients. Transplantation. 64:1997;1843-1846
14. Shapiro R., Nalesnik M., McCauley J., Fedorek S., Jordan M.L., Scantlebury V.P., et al. Posttransplant lymphoproliferative disorders in adult and pediatric renal transplant patients receiving tacrolimus-based immunosuppression. Transplantation. 68:1999;1851-1854
15. Adu D., Cockwell P., Ives N.J., Shaw J., Wheatley K. Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials. BMJ. 326:2003;789
16. Bunchman T., Navarro M., Broyer M., Sherbotie J., Chavers B., Tonshoff B., et al. The use of mycophenolate mofetil suspension in pediatric renal allograft recipients. Pediatr Nephrol. 16:2001;978-984